Evaluating the Validity of Risk Scoring in Predicting Pacemaker Rates following Transcatheter Aortic Valve Replacement.
Alexander M SpringMichael A CatalanoVikram PrasadBruce RutkinElana KossAlan HartmanPey-Jen YuPublished in: Journal of interventional cardiology (2020)
Our results demonstrated that, of the 479 patients analyzed, 236 (49.3%) received balloon-expandable valves and 243 (50.7%) received self-expanding valves. Pacemaker rates were higher in patients receiving self-expanding valves than those receiving balloon-expandable valves (25.1% versus 16.1%, p=0.018). The Emory risk score showed a moderate correlation with pacemaker requirement in patients receiving each valve type, with AUC for balloon-expandable and self-expanding valves of 0.657 and 0.645, respectively. Of the four risk score components, preoperative RBBB was the only predictor of pacemaker requirement with an AUC of 0.615 for both balloon-expandable and self-expanding valves. Conclusion. In our cohort, the Emory risk score had modest predictive utility for PPM insertion after balloon-expandable and self-expanding TAVR. The risk score did not offer better discriminatory utility than that of preoperative RBBB alone. Understanding the determinants of PPM insertion after TAVR can better guide patient education and postoperative management.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- patients undergoing
- vena cava
- end stage renal disease
- healthcare
- newly diagnosed
- chronic kidney disease
- left ventricular
- prognostic factors
- atrial fibrillation
- high intensity
- mitral valve
- peritoneal dialysis
- inferior vena cava
- patient reported